176 related articles for article (PubMed ID: 16282963)
1. [Voriconazole-medicalneeds, evidence, potential for the future].
Shirasawa H; Nagino K
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):223-8. PubMed ID: 16282963
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole: a new triazole antifungal.
Sabo JA; Abdel-Rahman SM
Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole: a new triazole antifungal agent.
Johnson LB; Kauffman CA
Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole.
Jeu L; Piacenti FJ; Lyakhovetskiy AG; Fung HB
Clin Ther; 2003 May; 25(5):1321-81. PubMed ID: 12867215
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole : a review of its use in the management of invasive fungal infections.
Scott LJ; Simpson D
Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
[TBL] [Abstract][Full Text] [Related]
8. [The role of voriconazole in the treatment of emerging mycoses].
Pastor FJ; Guarro J
Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Guinea J; Peláez T; Recio S; Torres-Narbona M; Bouza E
Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
[TBL] [Abstract][Full Text] [Related]
10. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
11. [Experience with voriconazole in invasive aspergillosis].
Thiel E; Schwartz S
Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole in newborns.
Kohli V; Taneja V; Sachdev P; Joshi R
Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole -- better chances for patients with invasive mycoses.
Ghannoum MA; Kuhn DM
Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole for serious fungal infections.
Gothard P; Rogers TR
Int J Clin Pract; 2004 Jan; 58(1):74-80. PubMed ID: 14994974
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole.
Naithani R; Kumar R
Indian Pediatr; 2005 Dec; 42(12):1207-12. PubMed ID: 16424557
[TBL] [Abstract][Full Text] [Related]
17. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Heyn K; Tredup A; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic profile of voriconazole.
Theuretzbacher U; Ihle F; Derendorf H
Clin Pharmacokinet; 2006; 45(7):649-63. PubMed ID: 16802848
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole. UK 109496.
Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
[No Abstract] [Full Text] [Related]
20. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
